News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Drug Development
Sound Pharmaceuticals, Inc. Release: New Drug For Hearing Loss Enters Clinical Testing
June 12, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
SEATTLE, June 12 /PRNewswire/ -- Sound Pharmaceuticals initiates clinical testing of SPI-1005 for the prevention and treatment of noise induced hearing loss.
Twitter
LinkedIn
Facebook
Email
Print
Clinical research
Phase I
Sound Pharmaceuticals
MORE ON THIS TOPIC
Earnings
Trial Failure of Vertex’s Next-Gen Pain Drug Mars Strong Q2 Earnings
August 5, 2025
·
3 min read
·
Dan Samorodnitsky
Neuroscience
Praxis’ Seizure Drug Demonstrates ‘Impressive’ Efficacy in Mid-Stage Trial
August 5, 2025
·
2 min read
·
Tristan Manalac
Regulatory
Report of Patient Deaths Sends Agios Shares Seesawing
August 5, 2025
·
2 min read
·
Tristan Manalac
CAR-T
Allogene Scraps Immunosuppressive Antibody After Patient Death in Lymphoma Trial
August 4, 2025
·
1 min read
·
Tristan Manalac
